When AIDS events were excluded from the non-fatal CCO, the beneficial effect of a higher CD4 count remained only for KS (aIRR 0.96, 95% CI [0.78, 0.96]; Supplementary Table S1). This evidence concerns the gene CD4 and Kaposi's sarcoma.